{"id":178027,"date":"2021-12-14T17:24:42","date_gmt":"2021-12-14T16:24:42","guid":{"rendered":"https:\/\/climatescience.press\/?p=178027"},"modified":"2021-12-14T17:24:43","modified_gmt":"2021-12-14T16:24:43","slug":"brazil-kicks-cv19-with-ivermectin","status":"publish","type":"post","link":"https:\/\/climatescience.press\/?p=178027","title":{"rendered":"Brazil Kicks CV19 with Ivermectin"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

Hospitalizations, Mortality Cut In Half After Brazilian City Offered Ivermectin<\/strong> To Everyone Pre-Vaccine is a report summarizing the experience of  Itajai<\/strong> offering Ivermectin as a prophylaxis against the disease.  H\/T Tyler Durden at zerohedge. The preprint study is Ivermectin prophylaxis used for COVID-19 reduces COVID-19 infection and mortality rates: A 220,517-subject, populational-level retrospective citywide.<\/strong><\/a> Excerpts below in italics with my bolds.<\/p>\n\n\n\n

<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

<\/p>\n\n\n\n

In Itajai, a Southern city of Brazil in the state of Santa Catarina, between July 2020 to December 2020, a citywide study was conducted involving 220,517 people<\/strong>. A total of 133,051 of these people (60.3% of the population) received ivermectin before being infected<\/strong> by COVID-19. A total of 87,466 people (39.7 %) did not receive or did not want to receive the ivermectin<\/strong> during the program, including its use for prophylactic, outpatient, inpatient therapeutical purposes, or after having COVID-19. The use of ivermectin was optional, based on the absence of contraindications, <\/em>and given upon medical discretion. Due to the uncertainty of reinfection with COVID-19, subjects with a history of previous COVID-19 did not participate in the program, notwithstanding, they were still permitted to use ivermectin prophylactically<\/em><\/p>\n\n\n\n

Baseline characteristics of the 9,956 subjects included in the above analysis are described in Table 1. Ivermectin users had a higher percentage of subjects over 50 years old<\/strong> (p < 0.0001), higher prevalence of T2D (Type 2 Diabetes)<\/strong> (p = 0.0004), hypertension<\/strong> (p < 0.0001), CVD (p = 0.03), and had a higher percentage of caucasians<\/strong> (p = 0.004), than non-users.<\/em><\/p>\n\n\n\n

Of the 7,345 subjects with COVID-19, there were 232 hospitalizations (3.16% hospitalization rate). Of the 4,311 ivermectin users<\/strong>, there were 105 hospitalizations (2.43% hospitalization rate<\/strong>), while among the 3,034 ivermectin non-users<\/strong>, there were 127 hospitalizations (4.18% hospitalization rate<\/strong>), with a reduction in hospitalization rate due to COVID-19 of 42% (RR, 0.58; 95%CI, 0.45-0.75; p < 0.0001).<\/em><\/p>\n\n\n\n

When the overall population is accounted for,\u00a0the risk of dying from COVID-19 was 0.09% among ivermectin non- users and 0.05% among ivermectin users<\/strong>, with a reduction of 48% of the chances of dying from COVID-19 (RR, 0.52; 95%CI, 0.37 \u20130.72; p = 0.0001).<\/em><\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

<\/p>\n\n\n\n

The report goes on to note that\u00a0these positive results are conservative for several reasons<\/strong>. As shown above,\u00a0persons electing to take I<\/b><\/span>VM were older and had co-morbidities<\/strong>, yet statistically faired better.\u00a0 Secondly,\u00a0the dose and frequency of ivermectin treatment was 0.2mg\/kg\/<\/strong>d<\/b>ay,<\/strong> i.e., giving one 6mg-tablet for every 30kg. for 2 days every 15 days.\u00a0 This is much less than protocols for sick patients.\u00a0 Also, the\u00a0IVM was self-administered<\/strong>\u00a0and may have been used less than prescribed.\u00a0\u00a0<\/em><\/p>\n\n\n\n

<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

<\/p>\n\n\n\n

When analyzed in populational, city level<\/strong>, irrespective of the the percentage of subjects that used ivermectin prophylactically, COVID-19 hospitalization rate decreased from 6.8%<\/strong> before the program with prophylactic use of ivermectin, to 1.8%<\/strong> after its beginning (RR, 0.27; 95%CO, 0.21 \u2013 0.33; p < 0.0001), and in COVID-19 mortality rate, from 3.4% to 1.4%<\/strong> (RR, 0.41; 95%CI 0.31 \u2013 0.55; p < 0.0001).<\/em><\/p>\n\n\n\n

When\u00a0compared to all other major cities in the State of Santa Catarina,<\/strong>\u00a0where Itaja\u00ed is located, differences in COVID-19 mortality rate between before July 7, 2020, and between July 7, 2020, and December 21, 2020,\u00a0Itaja\u00ed is ranked number one, and far from the second place.<\/strong>\u00a0These results indicate that medical-based optional prescription,\u00a0citywide covered ivermectin can have a positive impact in the healthcare system.<\/strong><\/em><\/p>\n\n\n\n

<\/a><\/p>\n\n\n\n

via Science Matters<\/mark><\/em><\/strong><\/p>\n\n\n\n

December 13, 2021<\/p>\n\n\n\n

\nBrazil Kicks CV19 with Ivermectin<\/a>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"

Hospitalizations, Mortality Cut In Half After Brazilian City Offered Ivermectin To Everyone Pre-Vaccine is a report summarizing the experience of  Itajai offering Ivermectin as a prophylaxis against the disease.  H\/T Tyler Durden at zerohedge. The preprint study is Ivermectin prophylaxis used for COVID-19 reduces COVID-19 infection and mortality rates: A 220,517-subject, populational-level retrospective citywide. Excerpts below in italics with […]<\/p>\n","protected":false},"author":121246920,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_crdt_document":"","advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[],"class_list":["post-178027","post","type-post","status-publish","format-standard","hentry","category-uncategorized","has-post-thumbnail","fallback-thumbnail"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/paxLW1-Kjp","jetpack-related-posts":[{"id":149251,"url":"https:\/\/climatescience.press\/?p=149251","url_meta":{"origin":178027,"position":0},"title":"Ivermectin Invictus: The Unsung Covid Victor","author":"uwe.roland.gross","date":"05\/07\/2021","format":false,"excerpt":"Invictus Games Toronto 2017 The triumph for Ivermectin over Covid19 is reviewed in biznews\u00a0Studies on Ivermectin show positive results as Covid-19 treatment.\u00a0 Excerpts in italics with my bolds. The use of Ivermectin for the prevention and treatment of Covid-19 has been the subject of much debate.\u00a0The World Health Organisation\u2018s\u00a0recommendation against\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2021\/07\/02017_invictus_011-1-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2021\/07\/02017_invictus_011-1-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2021\/07\/02017_invictus_011-1-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2021\/07\/02017_invictus_011-1-1.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":217380,"url":"https:\/\/climatescience.press\/?p=217380","url_meta":{"origin":178027,"position":1},"title":"Ivermectin reduces deaths by 92% for 10 cents a week","author":"uwe.roland.gross","date":"05\/09\/2022","format":false,"excerpt":"Even irregular use of ivermectin was still a lot better than none at all, but \u2014 and it\u2019s hardly surprising \u2014 regular use of ivermectin preemptively was the best.","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2022\/09\/image-255.png?fit=1024%2C576&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2022\/09\/image-255.png?fit=1024%2C576&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2022\/09\/image-255.png?fit=1024%2C576&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2022\/09\/image-255.png?fit=1024%2C576&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":181853,"url":"https:\/\/climatescience.press\/?p=181853","url_meta":{"origin":178027,"position":2},"title":"Bizarrely low dose Ivermectin still cut infections, hospitalization in half, deaths by 70%","author":"uwe.roland.gross","date":"09\/01\/2022","format":false,"excerpt":"Is your Minister of Health interested in saving lives, stopping infections or reducing the burden on hospitals? Did they ban\u00a0ivermectin\u00a0or study it? A study in a small Brazilian town suggests that half of all hospitalization of Covid cases and 70% of the deaths could be avoided at a cost of\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2022\/01\/0itajai-brazil.gif?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2022\/01\/0itajai-brazil.gif?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2022\/01\/0itajai-brazil.gif?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":198900,"url":"https:\/\/climatescience.press\/?p=198900","url_meta":{"origin":178027,"position":3},"title":"Reduced Risk of SARS CV2 Infection: IVM vs. VAX","author":"uwe.roland.gross","date":"08\/05\/2022","format":false,"excerpt":"A year ago, it was already evident that Ivermectin provided superior protection against SARS CV2 infection compared to Pfizer and Moderna mRNA vaccines. Bruce Sanders sent me the following analysis in pdf. Improving Covid 19 Outcomes:\u00a0 A Comparison of Prophylactic Measures \u2022\u00a0 Ivermectin (IVM) for humans is safe and improves\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2022\/05\/00sars-cv2-risk-top.png?fit=956%2C698&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2022\/05\/00sars-cv2-risk-top.png?fit=956%2C698&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2022\/05\/00sars-cv2-risk-top.png?fit=956%2C698&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2022\/05\/00sars-cv2-risk-top.png?fit=956%2C698&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":169604,"url":"https:\/\/climatescience.press\/?p=169604","url_meta":{"origin":178027,"position":4},"title":"Ivermectin Banned, Leunig Sacked: No Opportunity for Dissent When it Comes to Covid","author":"uwe.roland.gross","date":"26\/10\/2021","format":false,"excerpt":"I\u2019ve just put a pen through the name of the doctor who prescribed the triple therapy (Ivermectin, Zinc and Zithromax) for me back in September, as either a prophylaxis or cure for Covid. That same doctor gave me the AstraZeneca vaccine. They are potentially complementary, according to that registered Australian\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2021\/10\/0weisser-17-july_post.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2021\/10\/0weisser-17-july_post.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2021\/10\/0weisser-17-july_post.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2021\/10\/0weisser-17-july_post.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":168420,"url":"https:\/\/climatescience.press\/?p=168420","url_meta":{"origin":178027,"position":5},"title":"Nebraska AG Frees Doctors and Patients to Use HCQ and IVM","author":"uwe.roland.gross","date":"17\/10\/2021","format":false,"excerpt":"Jim Hoft reports at Gateway Pundit\u00a0Nebraska AG Issues Opinion on Doctors Prescribing HCQ and Ivermectin for COVID Treatment Will Not Face Punishment.\u00a0Excerpts in italics with my bolds. The Office of the\u00a0Attorney General in Nebraska\u00a0issued an\u00a0opinion\u00a0Friday in response\u00a0to the request of the Nebraska Department of Health and Human Services\u00a0that states there\u2019s\u00a0no\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/climatescience.press\/wp-content\/uploads\/2021\/10\/0ivm-for-sars-cv2-2.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/climatescience.press\/index.php?rest_route=\/wp\/v2\/posts\/178027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/climatescience.press\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/climatescience.press\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/climatescience.press\/index.php?rest_route=\/wp\/v2\/users\/121246920"}],"replies":[{"embeddable":true,"href":"https:\/\/climatescience.press\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=178027"}],"version-history":[{"count":6,"href":"https:\/\/climatescience.press\/index.php?rest_route=\/wp\/v2\/posts\/178027\/revisions"}],"predecessor-version":[{"id":178037,"href":"https:\/\/climatescience.press\/index.php?rest_route=\/wp\/v2\/posts\/178027\/revisions\/178037"}],"wp:attachment":[{"href":"https:\/\/climatescience.press\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=178027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/climatescience.press\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=178027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/climatescience.press\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=178027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}